XERS
Xeris Biopharma Holdings, Inc.
NASDAQ · USHealthcareBiotechnology
$8.60-2.27%
Price as of Jul 20, 2026
XERS valuation
Xeris Biopharma Holdings, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 38.44x
- P/E 2026E
- 47.66x
- P/E 2027E
- 23.36x
- P/E 2028E
- 13.53x
- P/S forward
- 3.74x
Trailing multiples
- P/E TTM
- 121.47x
- PEG TTM
- 0.57x
- Price / book
- 114.11x
- Price / sales
- 4.72x
- Price / cash flow
- 30.60x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 4.48x
- EV / EBITDA
- 30.57x
- EV / EBIT
- 39.28x
- Market cap
- $1.5B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.